Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview

被引:88
|
作者
Banerjee, Suvankar [1 ]
Adhikari, Nilanjan [1 ,2 ]
Amin, Sk Abdul [1 ]
Jha, Tarun [1 ]
机构
[1] Jadavpur Univ, Dept Pharmaceut Technol, Nat Sci Lab, Div Med & Pharmaceut Chem, POB 17020, Kolkata 700032, W Bengal, India
[2] ADAMAS Univ, Sch Pharmaceut Technol, Barasat Barrackpore Rd,PO Jagannathpur, Kolkata 700126, W Bengal, India
关键词
Histone deacetylase; HDAC8; Cancer; inhibitor; Structure-activity relationship (SAR); Quantitative structure-activity relationship (QSAR); DE-LANGE-SYNDROME; SUBEROYLANILIDE HYDROXAMIC ACID; ZINC-BINDING GROUP; BIOLOGICAL EVALUATION; PHASE-I; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURE; ACTIVITY ASSAY; UP-REGULATION; DESIGN;
D O I
10.1016/j.ejmech.2018.12.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The histone deacetylases (HDACs) enzymes provided crucial role in transcriptional regulation of cells through deacetylation of nuclear histone proteins. Discoveries related to the HDAC8 enzyme activity signified the importance of HDAC8 isoform in cell proliferation, tumorigenesis, cancer, neuronal disorders, parasitic/viral infections and other epigenetic regulations. The pan-HDAC inhibitors can confront these conditions but have chances to affect epigenetic functions of other HDAC isoforms. Designing of selective HDAC8 inhibitors is a key feature to combat the pathophysiological and diseased conditions involving the HDAC8 activity. This review is concerned about the structural and positional aspects of HDAC8 in the HDAC family. It also covers the contributions of HDAC8 in the pathophysiological conditions, a preliminary discussion about the recent scenario of HDAC8 inhibitors. This review might help to deliver the structural, functional and computational information in order to identify and design potent and selective HDAC8 inhibitors for target specific treatment of diseases involving HDAC8 enzymatic activity. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:214 / 240
页数:27
相关论文
共 50 条
  • [21] A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors
    Fontana, Anna
    Cursaro, Ilaria
    Carullo, Gabriele
    Gemma, Sandra
    Butini, Stefania
    Campiani, Giuseppe
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [22] A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing
    Simoben, Conrad V.
    Robaa, Dina
    Chakrabarti, Alokta
    Schmidtkunz, Karin
    Marek, Martin
    Lancelot, Julien
    Kannan, Srinivasaraghavan
    Melesina, Jelena
    Shaik, Tajith B.
    Pierce, Raymond J.
    Romier, Christophe
    Jung, Manfred
    Sippl, Wolfgang
    MOLECULES, 2018, 23 (03):
  • [23] Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?
    Amin, Sk Abdul
    Khatun, Samima
    Gayen, Shovanlal
    Das, Sanjib
    Jha, Tarun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 258
  • [24] Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus
    de Leval, L
    Waltregny, D
    Boniver, J
    Young, RH
    Castronovo, V
    Oliva, E
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (03) : 319 - 327
  • [25] Targeting of HDAC8 and investigational inhibitors in neuroblastoma
    Oehme, Ina
    Deubzer, Hedwig E.
    Lodrini, Marco
    Milde, Till
    Witt, Olaf
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (11) : 1605 - 1617
  • [26] Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants
    Marek, Martin
    Shaik, Tajith B.
    Heimburg, Tino
    Chakrabarti, Alokta
    Lancelot, Julien
    Ramos-Morales, Elizabeth
    Da Veiga, Cyrielle
    Kalinin, Dmitrii
    Melesina, Jelena
    Robaa, Dina
    Schmidtkunz, Karin
    Suzuki, Takayoshi
    Holl, Ralph
    Ennifar, Eric
    Pierce, Raymond J.
    Jung, Manfred
    Sippl, Wolfgang
    Romier, Christophe
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (22) : 10000 - 10016
  • [27] Mechanism of N-Acylthiourea-mediated Activation of Human Histone Deacetylase 8 (HDAC8) at Molecular and Cellular Levels
    Singh, Raushan K.
    Cho, Kyongshin
    Padi, Satish K. R.
    Yu, Junru
    Haldar, Manas
    Mandal, Tanmay
    Yan, Changhui
    Cook, Gregory
    Guo, Bin
    Mallik, Sanku
    Srivastava, D. K.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (10) : 6607 - 6619
  • [28] Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni
    Marek, Martin
    Kannan, Srinivasaraghavan
    Hauser, Alexander-Thomas
    Mourao, Marina Moraes
    Caby, Stephanie
    Cura, Vincent
    Stolfa, Diana A.
    Schmidtkunz, Karin
    Lancelot, Julien
    Andrade, Luiza
    Renaud, Jean-Paul
    Oliveira, Guilherme
    Sippl, Wolfgang
    Jung, Manfred
    Cavarelli, Jean
    Pierce, Raymond J.
    Romier, Christophe
    PLOS PATHOGENS, 2013, 9 (09)
  • [29] Histone Deacetylase-8 (HDAC8) Inhibition is Protective in a Murine Model of Renal Ischemia Reperfusion Injury (IRI).
    Hernandez, P. T.
    Concors, S. J.
    Aufhauser, D. D.
    Krumeich, L.
    Wang, Z.
    Ge, G.
    Beeler, A.
    Levine, M.
    Hancock, W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 747 - 747
  • [30] Kinetically selective and potent inhibitors of HDAC8
    Schweipert, Markus
    Jaensch, Niklas
    Sugiarto, Wisely Oki
    Meyer-Almes, Franz-Josef
    BIOLOGICAL CHEMISTRY, 2019, 400 (06) : 733 - 743